Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. (Q51480924)
Jump to navigation
Jump to search
scientific article published in February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. |
scientific article published in February 2007 |
Statements
1 reference
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. (English)
1 reference
Mitsuo Tanimoto
1 reference
Tomohito Gohda
1 reference
Shigeru Kaneko
1 reference
Shinji Hagiwara
1 reference
Maki Murakoshi
1 reference
Tatsuya Aoki
1 reference
Kaori Yamada
1 reference
Takamichi Ito
1 reference
Masakazu Matsumoto
1 reference
Satoshi Horikoshi
1 reference
Yasuhiko Tomino
1 reference
1 February 2007
1 reference
1 reference
56
1 reference
160-167
1 reference
2
1 reference
Identifiers
1 reference